Industry Insights

• 
  Popular APIs of the Year at Pharmasources.com PharmaSources
  December 10, 2024
  What are the APIs that caught the highest attention in the year at PharmaSources.com？
• 
  Has the Booming PD-1 Inhibitor Reached its Limit? Krebs Qin
  October 18, 2024
  In the field of oncology, Opdivo and Keytruda, as core immunotherapy agents for PD-1 inhibitors, have delivered significant survival benefits to patients with a variety of cancers.
• 
  Future Prospects of Small Molecule and Monoclonal Antibody Drugs in Oncology and Immunology Krebs Qin
  October 18, 2024
  Specifically, there is a balance between small molecules and monoclonal antibody drugs (mAbs) in the realm of oncology super blockbuster drugs, while immunology appears dominated by monoclonal antibodies and protein-based treatments.

• 
  What to Consider When Selecting DHS for Your Pharma Applications? Muhammad Asim Niazi
  December 04, 2024
  Dry Heat Sterilizer - DHS is an equipment used to sterilize items using hot air as a medium. The hot air at high temperatures is continuously circulated inside the chamber.

• 
  AI in Pharmacovigilance: Predicting & Preventing Drug Risks Nurah Ekhlaque
  November 19, 2024
• 
  Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases PharmaSources
  October 15, 2024
• 
  Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization PharmaSources
  October 15, 2024
  Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough manufacturing platform, announced today the appointment of Dr. Elisabeth Lackner to its Supervisory Board.

• 
  Research and Application of Artemisia Argyi Xiaonisha
  August 12, 2024
  Mugwort, also known as fragrant mugwort or Artemisia argyi, is a herbaceous plant belonging to the Compositae family.
• 
  Research Progress on the Application of Biologics in Pediatric Asthma Xiaomichong
  July 19, 2024
• 
  Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives Xiaomichong
  July 19, 2024

• 
  20 Years of Growth and Innovation in China, Fette Compacting Launches F30p Tablet Press PharmaSources
  December 13, 2024
  Interview Dr. Andreas Risch——Managing Director of Fette Compacting (China) Co., Ltd.